Basics AN2 Therapeutics, Inc. IPO Date: March 25, 2022 Sector: Healthcare Industry: Biotech Market Cap: $30.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 4.08% Avg Daily Range (30 D): $0.03 | 2.41% Avg Daily Range (90 D): $0.03 | 2.39% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 174 Avg Trade Size (Sh.) (30 D): 255 Avg Trade Size (Sh.) (90 D): 344 Institutional Trades Total Inst.Trades: 53 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $2.9M Avg Inst. Trade (90 D): $2.9M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.45M Avg Closing Trade (30 D): $.54M Avg Closing Trade (90 D): $.54M Avg Closing Volume: 225.92K     News May 21, 2024 @ 1:35 PM Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic... Source: Zacks Equity Research Feb 13, 2024 @ 1:08 PM ZoomInfo Technologies To Rally Around 50%? Here Ar... Source: Avi Kapoor Feb 12, 2024 @ 7:15 PM Nasdaq Edges Lower; ContextLogic Shares Surge Source: Avi Kapoor Feb 12, 2024 @ 6:07 PM Why Big Lots Shares Are Trading Lower By Around 31... Source: Avi Kapoor Feb 12, 2024 @ 5:30 PM Dow Surges Over 150 Points; Gilead Sciences To Acq... Source: Avi Kapoor Financials   TTM Q3 2025 TTM Basic EPS $-1.13 $-.31 $24.57 Diluted EPS $-1.13 $-.31 $24.52 Revenue $ M $ M $ 194.82B Gross Profit $ $ $ 173.15B Net Income / Loss $ -33.99M $ -9.35M $ 5.53B Operating Income / Loss $ -37.39M $ -10.04M $ 7.56B Cost of Revenue $ $ $ 21.67B Net Cash Flow $ -15.5M $ -.22M $ 893M PE Ratio